Emmaus Life Sciences Statistics
Total Valuation
EMMA has a market cap or net worth of 1.05 million. The enterprise value is 32.63 million.
| Market Cap | 1.05M |
| Enterprise Value | 32.63M |
Important Dates
The last earnings date was Monday, March 31, 2025.
| Earnings Date | Mar 31, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
EMMA has 63.87 million shares outstanding. The number of shares has increased by 19.07% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 63.87M |
| Shares Change (YoY) | +19.07% |
| Shares Change (QoQ) | -60.75% |
| Owned by Insiders (%) | 36.29% |
| Owned by Institutions (%) | n/a |
| Float | 36.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.06 |
| PB Ratio | -0.02 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.06 |
| EV / Sales | 1.96 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -14.20 |
Financial Position
The company has a current ratio of 0.11
| Current Ratio | 0.11 |
| Quick Ratio | 0.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -14.34 |
| Interest Coverage | -0.34 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -4.03% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 4.74% |
| Revenue Per Employee | 475,800 |
| Profits Per Employee | -184,371 |
| Employee Count | 35 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 0.72 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.50% in the last 52 weeks. The beta is 6.21, so EMMA's price volatility has been higher than the market average.
| Beta (5Y) | 6.21 |
| 52-Week Price Change | -83.50% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 44.09 |
| Average Volume (20 Days) | 3,675 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.10 |
Income Statement
In the last 12 months, EMMA had revenue of 16.65 million and -6.45 million in losses. Loss per share was -0.10.
| Revenue | 16.65M |
| Gross Profit | 15.45M |
| Operating Income | -1.89M |
| Pretax Income | -6.42M |
| Net Income | -6.45M |
| EBITDA | -1.87M |
| EBIT | -1.89M |
| Loss Per Share | -0.10 |
Balance Sheet
The company has 1.39 million in cash and 32.96 million in debt, giving a net cash position of -31.57 million or -0.49 per share.
| Cash & Cash Equivalents | 1.39M |
| Total Debt | 32.96M |
| Net Cash | -31.57M |
| Net Cash Per Share | -0.49 |
| Equity (Book Value) | -56.48M |
| Book Value Per Share | -0.88 |
| Working Capital | -56.79M |
Cash Flow
In the last 12 months, operating cash flow was -2.29 million and capital expenditures -12,000, giving a free cash flow of -2.30 million.
| Operating Cash Flow | -2.29M |
| Capital Expenditures | -12,000 |
| Free Cash Flow | -2.30M |
| FCF Per Share | -0.04 |
Margins
Gross margin is 92.79%, with operating and profit margins of -11.37% and -38.75%.
| Gross Margin | 92.79% |
| Operating Margin | -11.37% |
| Pretax Margin | -38.58% |
| Profit Margin | -38.75% |
| EBITDA Margin | -11.24% |
| EBIT Margin | -11.37% |
| FCF Margin | n/a |
Dividends & Yields
EMMA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -19.07% |
| Shareholder Yield | -19.07% |
| Earnings Yield | -612.37% |
| FCF Yield | -218.07% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
EMMA has an Altman Z-Score of -17.99. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -17.99 |
| Piotroski F-Score | n/a |